Sirolimus-eluting stent implantation for bare-metal in-stent restenosis: is there any evidence for a late catch-up phenomenon?-Reference-Cited by-同舟云学术

Sirolimus-eluting stent implantation for bare-metal in-stent restenosis: is there any evidence for a late catch-up phenomenon?

Published:2008-08 Issue:8 Volume:9 Page:783-788
ISSN:1558-2027
Container-title:Journal of Cardiovascular Medicine
language:en
Short-container-title:

Author:

Sheiban Imad,Chiribiri Amedeo,Galli Stefano,Biondi-Zoccai Giuseppe,Montorsi Piero,Beninati Serena,Fabbiocchi Franco,Moretti Claudio,Omedè Pierluigi,Trabattoni Daniela,Lotrionte Marzia,Trevi Gian Paolo,Bartorelli Antonio L

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference31 articles.

1. Bare metal stent restenosis is not a benign clinical entity;Chen;Am Heart J,2006

2. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the ‘real world’: the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry;Lemos;Circulation,2004

3. Angiographic and intravascular ultrasound predictors of in-stent restenosis;Kasaoka;J Am Coll Cardiol,1998

4. Interlesion dependence of the risk for restenosis in patients with coronary stent placement in multiple lesion;Kastrati;Circulation,1998

5. Vessel size and long term outcome after coronary stent placement;Elezi;Circulation,1998

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ultra-thin everolimus-eluting stents in atherosclerotic lesions: Three years follow-up with subgroup analysis of ultra-long stents;Indian Heart Journal;2023-07

2. Romanian Patients Who Experience in-Stent Restenosis After St-Elevation Myocardial Infarction: The Experience of a Tertiary Center;Internal Medicine;2021-05-01

3. The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era;Journal of Interventional Cardiology;2019-07-01

4. Nine-month Angiographic and Two-year Clinical Follow-up of Novel Biodegradable-polymer Arsenic Trioxide-eluting Stent Versus Durable-polymer Sirolimus-eluting Stent For Coronary Artery Disease;Chinese Medical Journal;2015-03-20

5. Long-term Outcomes of Drug-eluting versus Bare-metal Stent for ST-elevation Myocardial Infarction;Arquivos Brasileiros de Cardiologia;2014